Art

J-GLOBAL ID：201702229721336690   Reference number：17A1192117

ApoC-IIIアンチセンス医薬

Author (2)： WADA FUMITO (国立循環器病研究セ 研) ,  SHIBA MARIKO (国立循環器病研究セ 研)
Material： 循環器内科  (Cardioangiology)
Volume： 82  Issue： 3  Page： 296-301  Publication year： Sep. 28, 2017 
JST Material Number： Y0038A  ISSN： 1884-2909  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Apolipoprotein C-III ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1192117&from=J-GLOBAL&jstjournalNo=Y0038A") }}

JST classification (1)： Clinical application of drugs acting on lipid metabolism  (GW13050X)

Reference (22)：

• Gotto AM Jr, Bierman EL, Connor WE, et al. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriocslerosis. Circulation 1984 ; 69 : 1065A.
• Brown MS, Goldstein JL. Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man. Science 1974 ; 185: 61.
• Endo A, Kuroda M, Tsujita Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot (Tokyo) 1976 ; 29 : 1346.
• Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999 ; 341 : 410.
• ACCORD Study Group, Ginsberg HN, Elam MB, et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010 ; 362: 1563.